AI is redefining pharma in 2026.
Abstract submissions are still open for our AI-Driven Drug Discovery & Development session at
InnoPharm2026.Gain global visibility connect with pharma and AI leaders. Present your research on AI, machine learning, predictive toxicology, and data-driven drug development, and be part of shaping the future of pharmaceutical innovation.
Submit now: https://lnkd.in/gVbPF7bh
contact us: gayatri@coinsymposia.com/contact@pharmaresearchers.com
For more info: https://pharm-science.com/
Stay tuned for more updates…



Comments
Post a Comment